# Orbital Radiotherapy in Grave's Ophthalmopathy 1 Week vs 2 Weeks (OraGO-1 Trial)

> **NCT06392906** · PHASE3 · RECRUITING · sponsor: **Janjira Petsuksiri** · enrollment: 68 (estimated)

## Conditions studied

- Thyroid Associated Ophthalmopathy

## Interventions

- **RADIATION:** Short course radiation therapy
- **RADIATION:** Standard course radiation therapy

## Key facts

- **NCT ID:** NCT06392906
- **Lead sponsor:** Janjira Petsuksiri
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-11
- **Primary completion:** 2028-04-30
- **Final completion:** 2028-10-31
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2024-12-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06392906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06392906, "Orbital Radiotherapy in Grave's Ophthalmopathy 1 Week vs 2 Weeks (OraGO-1 Trial)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06392906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*